HU166989B - - Google Patents

Info

Publication number
HU166989B
HU166989B HUEI419A HUEI000419A HU166989B HU 166989 B HU166989 B HU 166989B HU EI419 A HUEI419 A HU EI419A HU EI000419 A HUEI000419 A HU EI000419A HU 166989 B HU166989 B HU 166989B
Authority
HU
Hungary
Application number
HUEI419A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU166989B publication Critical patent/HU166989B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HUEI419A 1971-04-30 1972-04-28 HU166989B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
HU166989B true HU166989B (https=) 1975-07-28

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
HUEI419A HU166989B (https=) 1971-04-30 1972-04-28

Country Status (23)

Country Link
US (1) US3758683A (https=)
JP (1) JPS5735185B1 (https=)
BE (1) BE782651A (https=)
CA (1) CA976085A (https=)
CH (1) CH566784A5 (https=)
CS (1) CS209458B2 (https=)
DD (1) DD100708A5 (https=)
DE (1) DE2219635C3 (https=)
DK (1) DK131760C (https=)
ES (1) ES402176A1 (https=)
FI (1) FI49773C (https=)
FR (1) FR2134658B1 (https=)
GB (1) GB1385086A (https=)
HU (1) HU166989B (https=)
IL (1) IL39181A (https=)
NL (1) NL178258C (https=)
NO (1) NO137178C (https=)
PL (1) PL86966B1 (https=)
RO (1) RO64387A (https=)
SE (1) SE378066B (https=)
SU (1) SU508162A3 (https=)
YU (1) YU36155B (https=)
ZA (1) ZA722243B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
FI882921A7 (fi) * 1986-10-20 1988-06-17 Novo Ind A/S Protamiinisinkki-insuliinivalmisteet.
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
CN102596175A (zh) 2009-07-06 2012-07-18 赛诺菲-安万特德国有限公司 含有甲硫氨酸的水性胰岛素制备物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
MY180661A (en) 2009-11-13 2020-12-04 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PL2611458T3 (pl) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
JP7761567B2 (ja) 2020-02-18 2025-10-28 ノヴォ ノルディスク アー/エス 医薬製剤
WO2025031391A1 (zh) * 2023-08-07 2025-02-13 浙江大学 一种糖响应鱼精蛋白胰岛素及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
FI49773B (https=) 1975-06-30
NO137178B (no) 1977-10-10
CH566784A5 (https=) 1975-09-30
GB1385086A (en) 1975-02-26
DE2219635B2 (de) 1980-11-27
SE378066B (https=) 1975-08-18
PL86966B1 (https=) 1976-06-30
DK131760B (da) 1975-09-01
ZA722243B (en) 1973-11-28
ES402176A1 (es) 1975-03-01
RO64387A (fr) 1979-07-15
IL39181A0 (en) 1972-06-28
NL178258C (nl) 1986-02-17
NO137178C (no) 1978-01-18
IL39181A (en) 1974-09-10
SU508162A3 (ru) 1976-03-25
DK131760C (da) 1976-02-02
NL178258B (nl) 1985-09-16
FI49773C (fi) 1975-10-10
YU36155B (en) 1982-02-25
FR2134658B1 (https=) 1975-10-17
DE2219635C3 (de) 1981-10-15
FR2134658A1 (https=) 1972-12-08
JPS5735185B1 (https=) 1982-07-27
CA976085A (en) 1975-10-14
BE782651A (fr) 1972-10-26
DD100708A5 (https=) 1973-10-05
NL7205865A (https=) 1972-11-01
CS209458B2 (en) 1981-12-31
DE2219635A1 (de) 1972-11-09
US3758683A (en) 1973-09-11
YU114272A (en) 1981-06-30

Similar Documents

Publication Publication Date Title
ATA136472A (https=)
AR196074A1 (https=)
AU2658571A (https=)
AU2691671A (https=)
AU2952271A (https=)
AU2894671A (https=)
AU2941471A (https=)
AU2742671A (https=)
AU2726271A (https=)
AU2485671A (https=)
AU2684071A (https=)
AU3005371A (https=)
AU2564071A (https=)
AU2473671A (https=)
AU2836771A (https=)
AU3038671A (https=)
AU2503871A (https=)
AU3025871A (https=)
AU2577671A (https=)
AU2588771A (https=)
AU2654071A (https=)
AU2938071A (https=)
AU2669471A (https=)
AU2456871A (https=)
AU2684171A (https=)